George Soros, Mind of a Businessman, Heart of a Philanthropist

“Self-made millionaire” is not a title that comes as an exaggeration when talking about George Soros. He had many struggles since he was young due to the fact he had to live under the pro-Nazi regime before he had the chance to escape to London and earn a degree in Economics. This is where his journey on becoming one of the richest men to walk on Earth began. Soros has a great vision on the things he had to do to reach the top and leave a mark in history. His first step was to go to New York and start working in Wall Street where he made a fortune by creating his own hedge fund.He decided it was time to give back and start his philanthropic endeavor, one of his biggest feats was when he founded Open Society Foundation in 1993 that was created by Soros to give financial support the civil society groups that were in need.

This society has made huge collaborations all over the globe in several matters like the defense of human rights, right and justice, health and many more.However, Soros philanthropic efforts don’t end there. It is well known that Soros has had huge participation in the attempt to end Africa’s extreme poverty by contributing $75,000 million to projects that have positive approaches on how to do it. After the fall of the Berlin Wall, and Hungary was starting to recuperate from all the problems that came before that, Soros gave a hand by strengthening the education of the nation with a sizable donation of $880 million to the Central European University in Budapest who he helped found.

On top of the financial and philanthropical contributions that Soros has made, he also has had an active participation politics, with liberal ideals since many years, he has promoted his agenda with help of his foundation which gives him a lot of influence due to the fact that it has many branches all over the world. It is clear that Soros has a great influence in the world of politics and it comes with no surprise being a man with such a great number of international contributions. And to this date it stills amazes the world that the man that had to suffer many hardships since his birth and had to flee from his nation, manage to grow and become an individual of such wealth that was capable of helping the process of rebuilding the country where he once had to leave. Because of all of these reasons, George Soros is one of the most influential philanthropists in the world, and his Open Society foundations have helped thousands of communities around the globe and the United States.

George Soros: Influential Business Magnate

War, violence, discrimination, and equality – that is how the young George Soros saw the world when he was still a child. His birth country of Hungary is under Nazi occupation, and his family being Jewish is subject to harsh punishments and even death. Good thing that they managed to escape, and the young George Soros survived the deadliest war in the history of mankind. George Soros, during his younger years, decided to leave Hungary for the United Kingdom, where he decided to study. He enrolled himself in a university and took up a course about business and economics. He balanced his time working and studying, often taking up two jobs in a single day to meet his daily needs. After graduating from the university, he decided to move to the United States and see for himself if he could reach the American Dream.

Living in the United States is much more difficult than living in Europe for the young George Soros. At first, he is having a hard time looking for jobs that would support him for staying in the United States, until he found out the secrets of trading. George Soros initially played with the stock market and enriched himself with knowledge on how it works. When he decided that it is time for him to try it out using his own money, the stocks that he purchased spiked, and his returns were huge. He used some of the money that he made from trading in establishing a hedge fund. This is where the majority of his wealth originated, and because of how fast wealth is being generated on the corporations that he owned, he became recognized as the most successful investor in the history of the United States.

George Soros went on trading stocks and foreign exchanges, accumulating more wealth in the process. In his mind, George Soros wanted to help everyone who has been victims of the Second World War, especially the children, and wanted the future generations not to experience what he experienced when he was a child. He soon established the Open Society Foundations, which aims to abolish war, violence, discrimination, and equality in the face of the Earth, and he is directly funding all of the organizations who are part of the network.One of the most recent involvements of George Soros was with the Ferguson Protests. It was reported that he give huge amount of money to the demonstrators, in order for them to fight for what they believe is right. The protest stems from the murder of an African American by the police, and the people are demanding justice. Another example of him giving away millions of dollars for donations would be his support for Hillary’s Clinton’s bid for presidency. Even if Hillary Clinton lost, George Soros stays behind her back, supplying whatever she needs that agrees with his principles.

Clay Siegall And The Building And Future Of Seattle Of Seattle Genetics

Founded in 1998, Seattle Genetics uses human antibodies to create effective therapies to treat cancer. Now a major player in the Seattle biotech community, the company has 900 employees, a $10 billion market value and is Washington’s largest biotech company. And with its consistent growth and investments in its flagship drug Adcetris, it’s well on its way to becoming a major pharmaceutical company. According to co-founder, CEO, president and chairman Clay Siegall, Seattle Genetics is an emerging multiproduct, global, oncology company.

Seattle Genetics has several viable drugs in its development pipeline. It’s also focused on developing and marketing new products. Initially the company sold the international rights to its products. Now, it has an office in Switzerland handlings its international marketing. Sales are up 46%, Seattle Genetics’ stock price has tripled in the past 5 years and spending on its specialty, antibody-drug conjugate development, is up 64%. Those drugs kill cancerous cells without damaging healthy cells. The company has developed 11 of them. Siegall says 4 of them are ready for use.

Seattle Genetics’ FDA-approved ADC Adcetris could generate annual sales of $1 billion if it becomes oncologist’s drug of choice. So far it’s been a moderate success. The company is studying ways to use it in combination with immunotherapies to create new markets. Positive results from an on-going clinical study would propel Adcetris into a billion dollar product. But the cost of new drugs is a touchy topic. Seattle Genetics also has the cancer drugs 33A, 22ME and LIV1 poised to be released. The question for Clay Siegall is will Seattle Genetics become a pharma giant like Genentech or be bought out.

Clay Siegall became interested in cancer research after one of his relatives died from the disease. He attended the University of Maryland and earned a bachelor’s degree in Zoology. He then graduated from George Washington University with a doctorate in Genetics. Siegall worked with some of the top cancer research companies. They included Bristol-Myers Squibb Pharmaceutical Research Institute, National Institutes of Health and the National Cancer Institute.

Since founding Seattle Genetics, he has raised over $675 million to support the company’s activities from public and private funding sources. He held the company’s IPO in 2001. In addition to his research and fundraising activities, Dr. Siegall holds 15 patents and has written pieces for over 70 publications. He’s also on the board of the biotech company Alder BioPharmaceuticals.

Richard Blair Offers Wealth Solutions to More than Just The Financially Struggling

One common misconception is that only the financially struggling people are the ones that are in need of financial assistance. The truth is that people of all walks can use financial assistance. For one thing, people who have a lot of wealth often don’t know what to do with it. This is where financial aid comes in for the wealthy. After all, the wealthy are not immune to losing all of their money. This is one of the reasons that people like Richard Blair of Wealth Solutions is one of the most valuable people to seek after for advice. Learn more:


However, for people that struggle with finances, there is plenty of assistance and advice as well. After all, they need a lot of help in bringing themselves out of their financial circumstances. Richard Blair of Wealth Solutions can come up with a lot of good ideas for what people can do with their money. There are a lot of ways that people can invest them so that they can actually increase the amount of money they have ( One thing that Richard Blair would advise people that are struggling with their money is that they seek out investment opportunities that are very low in risk.


One thing that would probably not be good for people who are struggling with finances to do is to try to make trades in the market. One problem with this is that people run their risk of losing tons of money. This is especially true for people who do not know how the market works. At least with making investments in savings accounts and other types of interest gaining investments, people will be able to gain interest at a slow but steady rate.


Richard Blair of Wealth Solutions can open people’s eyes to a lot of concepts that can bring forth something valuable. Among the concepts that people can learn about is compounding. This is one effective way to profit off of the money that has been invested into the accounts. As one gains a lot of capital and breaks free of his financial trap, he can do more with his money. Learn more:

Jason Hope Turns to Social Media for Marketing Success

Jason Hope is something of a entrepreneurial genius not just for the hard work he has done with vAtomic Systems, but also his ability to extend himself into several different fields. Hope is a renowned futurist, an author, a public speaker and a tech innovator. He has consistently set for success and other entrepreneurs should take notice. We took a moment to delve into what makes him tick and what makes businesses so successful.

We have seen Jason Hope turn to Internet of Things as his next great venture. The Internet of Things refers to the way by which the internet and our day-to-day objects interface with one another. think of things like your coffee maker, your security system, your car — imagine how they can interact with the internet controlling them. Hope believes that the Internet of Things is the next great industry in the tech field and we would be hard pressed to disagree. While that is Jason Hope’s primary focus at the moment, it is far from his only one.

Hope has been working with vAtomic Systems for awhile now in order to cement himself in the mobile communication industry. vAtomic Systems focuses on bringing out digital products and utilizing them with real world money. These micro transactions have become the life blood of independent application developers all over the world. This company in and of itself has done much to establish Hope as a prominent innovator within the tech field.

Of course, success won’t come to you unless you know how to court it. Hope has turned to social media time and again in order to establish his work and get the word out. Jason Hope believes that social media is ready made to improve your business, your concepts, and your branding. Hope says, “Social media is a tried and true method of marketing that’s readily available.” You can see how Hope turns to social media in order to reinforce his concepts and find ways to connect with customers. Hope continues to impress and we cannot wait to see what comes next in his career.

Learn More:

The Fight against Rare and Orphan Diseases at Amicus Therapeutics

As the world evolves, there emerges different kind of diseases with different treatment requirements. These diseases can at some point prove to be stubborn thus needing special attention by the health organization. There is much need of active commercial organizations and sufficient clinical programs to initiate every possible means of fighting these of diseases. Currently, there are plenty of patients trapped in the rare disease community who need intensive care but are suffering because of either lack of knowledge or lack of enough care facilities. However, there are few available therapeutic centers such as the Amicus Therapeutics that offer services on such rare diseases.


Amicus Therapeutics attained its publicity under the NASDAQ trading symbol FOLD (YahooFinance). The biopharmaceutical company is an American public facility based in Cranbury New Jersey. Amicus Therapeutics was founded in the year 2002 by John Crowley and is focused mainly on rare and orphan diseases, collectively known as lysosomal storage disorders. The company previously received financial supports from various venture capital firms such as; radius ventures, Canaan Partners, and new enterprise associates among others. To achieve higher goals in its therapeutic fields, Amicus Therapeutics did a three years deal collaboration with GlaxoSmithKline and JCR Pharmaceutical. The collaboration was as a result of the advancement of Migalastat Monotherapy  and was to investigate co-formulation with recombinant alpha galactosidase


According to sources, Amicus Therapeutics is a contract manufacturer oriented company, it does not manufacture on its own drugs. The company has to receive support from other prominent organizations such as the Shire Company. Despite its financial mayhems, the company managed to put up another research site branch in San Diego in the year 2008. At some point, the company faced financial difficulties; this was due to the termination of the long term financial relationship with Shire Company in the year 2001. The company nearly lost direction since the Shire agreement termination led to a massive loss of shares.


With the collaboration of David Geffen School of medicine, Michael J. Fox Foundation donated U.S$ 500,000 for study conduct support. In addition, U.S 210,300 was granted to the firm with Alzheimer Drug Discovery Center in collaborations with Icahn School of Medicine ( After that, Amicus Therapeutic managed to acquire various medical centers such as the Calliddus Biopharma in 2013 and Sciodem in 2015 that cost about U.S $947 million both in cash and stock.

Visit Amicus Therapeutics on GlassDoor

Scott Rocklage and Scientific Research

There is a line of work that few people know about. A venture capitalist is someone who connects to people that want to get things done. It can be in many walks of life and several professions. Scott M. Rockledge Ph.D. of 5 AM Ventures is one of those venture capitalists. Learn more about Michael Lacey:

He works in science and works with business opportunities that are in the early stages. Let’s take a look at some other aspects that make him who he is today.

Scott M. Rocklag Ph.D. joined the 5 am Venture company around 2003 and he became their managing partner in 2004. He has over 30 years of experience in healthcare managing and knows how to lead a program towards success. Working with several new drug applications, he has led studies in those drugs. His responsibility was to find and manage people for the study.

He goes between doctors and the labs where the scientific work on the latest creation. Saving lives by finding ways to create new drugs that can help the world to be a healthier place. Not only that, but he makes a lot of money doing so. It’s a winning combination for everyone involved.

He sites his ability to be well organized as his highest level of needed asset to do what he does for a living. He also states that he believes in risk-taking. You cannot be a venture capitalist without that aspect.

Scott values the ability to trust his instincts in order to find the best employee for the job. He has been successfully placing candidates for over thirty years.

He graduated from the University of California with a bachelor of science degree in Chemistry. He later went on to attend and graduate with his Ph.D. from MIT. There, he led research on these drug studies. Located in Boston now, he holds 30 patents and is always pursuing more.

He is published and participated in some of the most prestigious events in the filed of chemistry over the years.

Read more: Sccot Racklage | Bloomberg